TERNIUM SA-SPONSORED ADR (TX) Fundamental Analysis & Valuation

NYSE:TX • US8808901081

Current stock price

43.04 USD
+1.25 (+2.99%)
At close:
43.04 USD
0 (0%)
After Hours:

This TX fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

5

1. TX Profitability Analysis

1.1 Basic Checks

  • In the past year TX was profitable.
  • TX had a positive operating cash flow in the past year.
  • TX had positive earnings in 4 of the past 5 years.
  • TX had a positive operating cash flow in each of the past 5 years.
TX Yearly Net Income VS EBIT VS OCF VS FCFTX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B 2B 3B 4B 5B

1.2 Ratios

  • The Return On Assets of TX (1.80%) is better than 62.50% of its industry peers.
  • The Return On Equity of TX (3.56%) is better than 63.13% of its industry peers.
  • The Return On Invested Capital of TX (2.83%) is comparable to the rest of the industry.
  • Measured over the past 3 years, the Average Return On Invested Capital for TX is significantly below the industry average of 59.89%.
  • The last Return On Invested Capital (2.83%) for TX is well below the 3 year average (7.51%), which needs to be investigated, but indicates that TX had better years and this may not be a problem.
Industry RankSector Rank
ROA 1.8%
ROE 3.56%
ROIC 2.83%
ROA(3y)1.45%
ROA(5y)7.37%
ROE(3y)2.85%
ROE(5y)11.96%
ROIC(3y)7.51%
ROIC(5y)13.39%
TX Yearly ROA, ROE, ROICTX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 20 30

1.3 Margins

  • TX has a better Profit Margin (2.72%) than 63.13% of its industry peers.
  • TX's Profit Margin has declined in the last couple of years.
  • The Operating Margin of TX (4.52%) is comparable to the rest of the industry.
  • In the last couple of years the Operating Margin of TX has declined.
  • TX has a Gross Margin (15.08%) which is comparable to the rest of the industry.
  • TX's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 4.52%
PM (TTM) 2.72%
GM 15.08%
OM growth 3Y-35.35%
OM growth 5Y-17.95%
PM growth 3Y-36.75%
PM growth 5Y-21.1%
GM growth 3Y-14.27%
GM growth 5Y-4.24%
TX Yearly Profit, Operating, Gross MarginsTX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 20 30

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. TX Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), TX is destroying value.
  • TX has about the same amout of shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, TX has about the same amount of shares outstanding.
  • Compared to 1 year ago, TX has a worse debt to assets ratio.
TX Yearly Shares OutstandingTX Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M
TX Yearly Total Debt VS Total AssetsTX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B 20B

2.2 Solvency

  • An Altman-Z score of 2.34 indicates that TX is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • TX has a worse Altman-Z score (2.34) than 66.88% of its industry peers.
  • TX has a Debt/Equity ratio of 0.16. This is a healthy value indicating a solid balance between debt and equity.
  • TX has a Debt to Equity ratio of 0.16. This is comparable to the rest of the industry: TX outperforms 50.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.16
Debt/FCF N/A
Altman-Z 2.34
ROIC/WACC0.29
WACC9.89%
TX Yearly LT Debt VS Equity VS FCFTX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2B 4B 6B 8B 10B

2.3 Liquidity

  • TX has a Current Ratio of 2.49. This indicates that TX is financially healthy and has no problem in meeting its short term obligations.
  • With a Current ratio value of 2.49, TX perfoms like the industry average, outperforming 49.38% of the companies in the same industry.
  • A Quick Ratio of 1.45 indicates that TX should not have too much problems paying its short term obligations.
  • The Quick ratio of TX (1.45) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 2.49
Quick Ratio 1.45
TX Yearly Current Assets VS Current LiabilitesTX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B 10B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. TX Growth Analysis

3.1 Past

  • TX shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -34.94%.
  • The Earnings Per Share has been decreasing by -6.42% on average over the past years.
  • Looking at the last year, TX shows a very negative growth in Revenue. The Revenue has decreased by -11.56% in the last year.
  • Measured over the past years, TX shows a quite strong growth in Revenue. The Revenue has been growing by 12.31% on average per year.
EPS 1Y (TTM)-34.94%
EPS 3Y-37.86%
EPS 5Y-6.42%
EPS Q2Q%-56.64%
Revenue 1Y (TTM)-11.56%
Revenue growth 3Y-1.66%
Revenue growth 5Y12.31%
Sales Q2Q%-2.61%

3.2 Future

  • The Earnings Per Share is expected to grow by 38.03% on average over the next years. This is a very strong growth
  • The Revenue is expected to grow by 4.52% on average over the next years.
EPS Next Y87.58%
EPS Next 2Y53.83%
EPS Next 3Y38.03%
EPS Next 5YN/A
Revenue Next Year4.34%
Revenue Next 2Y5.83%
Revenue Next 3Y4.25%
Revenue Next 5Y4.52%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
TX Yearly Revenue VS EstimatesTX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 5B 10B 15B 20B
TX Yearly EPS VS EstimatesTX Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 5 10 15 20

More info and screens

Find the best growth stocksShow best growing peers

6

4. TX Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 19.93, the valuation of TX can be described as rather expensive.
  • Based on the Price/Earnings ratio, TX is valued a bit cheaper than the industry average as 80.00% of the companies are valued more expensively.
  • The average S&P500 Price/Earnings ratio is at 27.18. TX is valued slightly cheaper when compared to this.
  • With a Price/Forward Earnings ratio of 10.62, the valuation of TX can be described as very reasonable.
  • Based on the Price/Forward Earnings ratio, TX is valued a bit cheaper than 79.38% of the companies in the same industry.
  • When comparing the Price/Forward Earnings ratio of TX to the average of the S&P500 Index (37.96), we can say TX is valued rather cheaply.
Industry RankSector Rank
PE 19.93
Fwd PE 10.62
TX Price Earnings VS Forward Price EarningsTX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, TX is valued cheaper than 98.13% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 4.07
TX Per share dataTX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60

4.3 Compensation for Growth

  • TX's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • TX's earnings are expected to grow with 38.03% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.23
PEG (5Y)N/A
EPS Next 2Y53.83%
EPS Next 3Y38.03%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

5

5. TX Dividend Analysis

5.1 Amount

  • TX has a Yearly Dividend Yield of 6.55%, which is a nice return.
  • TX's Dividend Yield is rather good when compared to the industry average which is at 1.09. TX pays more dividend than 96.25% of the companies in the same industry.
  • TX's Dividend Yield is rather good when compared to the S&P500 average which is at 1.82.
Industry RankSector Rank
Dividend Yield 6.55%

5.2 History

  • TX has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
TX Yearly Dividends per shareTX Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1 2 3 4 5

5.3 Sustainability

  • 124.65% of the earnings are spent on dividend by TX. This is not a sustainable payout ratio.
DP124.65%
EPS Next 2Y53.83%
EPS Next 3Y38.03%
TX Yearly Income VS Free CF VS DividendTX Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B 2B 3B
TX Dividend Payout.TX Dividend Payout, showing the Payout Ratio.TX Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

TX Fundamentals: All Metrics, Ratios and Statistics

TERNIUM SA-SPONSORED ADR

NYSE:TX (4/13/2026, 8:04:00 PM)

After market: 43.04 0 (0%)

43.04

+1.25 (+2.99%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)02-18
Earnings (Next)05-05
Inst Owners16.04%
Inst Owner Change0%
Ins Owners0%
Ins Owner Change0%
Market Cap8.45B
Revenue(TTM)15.61B
Net Income(TTM)425.23M
Analysts75
Price Target41.5 (-3.58%)
Short Float %3.16%
Short Ratio2.8
Dividend
Industry RankSector Rank
Dividend Yield 6.55%
Yearly Dividend0.27
Dividend Growth(5Y)N/A
DP124.65%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-62.12%
Min EPS beat(2)-88.07%
Max EPS beat(2)-36.18%
EPS beat(4)1
Avg EPS beat(4)-35.24%
Min EPS beat(4)-88.07%
Max EPS beat(4)31.12%
EPS beat(8)3
Avg EPS beat(8)-20.69%
EPS beat(12)6
Avg EPS beat(12)5.62%
EPS beat(16)8
Avg EPS beat(16)0.11%
Revenue beat(2)0
Avg Revenue beat(2)-4.12%
Min Revenue beat(2)-5.13%
Max Revenue beat(2)-3.11%
Revenue beat(4)0
Avg Revenue beat(4)-4.02%
Min Revenue beat(4)-5.73%
Max Revenue beat(4)-2.12%
Revenue beat(8)0
Avg Revenue beat(8)-4.44%
Revenue beat(12)1
Avg Revenue beat(12)-1.5%
Revenue beat(16)2
Avg Revenue beat(16)-1.91%
PT rev (1m)1.36%
PT rev (3m)6.59%
EPS NQ rev (1m)-3.89%
EPS NQ rev (3m)-6.74%
EPS NY rev (1m)-9.2%
EPS NY rev (3m)-15.74%
Revenue NQ rev (1m)-1.62%
Revenue NQ rev (3m)-1.73%
Revenue NY rev (1m)-2.3%
Revenue NY rev (3m)-2.99%
Valuation
Industry RankSector Rank
PE 19.93
Fwd PE 10.62
P/S 0.54
P/FCF N/A
P/OCF 3.65
P/B 0.71
P/tB 0.77
EV/EBITDA 4.07
EPS(TTM)2.16
EY5.02%
EPS(NY)4.05
Fwd EY9.41%
FCF(TTM)-0.95
FCFYN/A
OCF(TTM)11.79
OCFY27.38%
SpS79.51
BVpS60.84
TBVpS55.74
PEG (NY)0.23
PEG (5Y)N/A
Graham Number54.38
Profitability
Industry RankSector Rank
ROA 1.8%
ROE 3.56%
ROCE 3.58%
ROIC 2.83%
ROICexc 3.37%
ROICexgc 3.58%
OM 4.52%
PM (TTM) 2.72%
GM 15.08%
FCFM N/A
ROA(3y)1.45%
ROA(5y)7.37%
ROE(3y)2.85%
ROE(5y)11.96%
ROIC(3y)7.51%
ROIC(5y)13.39%
ROICexc(3y)9.06%
ROICexc(5y)16.55%
ROICexgc(3y)9.64%
ROICexgc(5y)17.86%
ROCE(3y)9.5%
ROCE(5y)16.95%
ROICexgc growth 3Y-43.7%
ROICexgc growth 5Y-17.88%
ROICexc growth 3Y-43.3%
ROICexc growth 5Y-17.28%
OM growth 3Y-35.35%
OM growth 5Y-17.95%
PM growth 3Y-36.75%
PM growth 5Y-21.1%
GM growth 3Y-14.27%
GM growth 5Y-4.24%
F-Score4
Asset Turnover0.66
Health
Industry RankSector Rank
Debt/Equity 0.16
Debt/FCF N/A
Debt/EBITDA 1.31
Cap/Depr 317.24%
Cap/Sales 16.02%
Interest Coverage 250
Cash Conversion 154.89%
Profit Quality N/A
Current Ratio 2.49
Quick Ratio 1.45
Altman-Z 2.34
F-Score4
WACC9.89%
ROIC/WACC0.29
Cap/Depr(3y)263.55%
Cap/Depr(5y)194.66%
Cap/Sales(3y)11.63%
Cap/Sales(5y)8.34%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-34.94%
EPS 3Y-37.86%
EPS 5Y-6.42%
EPS Q2Q%-56.64%
EPS Next Y87.58%
EPS Next 2Y53.83%
EPS Next 3Y38.03%
EPS Next 5YN/A
Revenue 1Y (TTM)-11.56%
Revenue growth 3Y-1.66%
Revenue growth 5Y12.31%
Sales Q2Q%-2.61%
Revenue Next Year4.34%
Revenue Next 2Y5.83%
Revenue Next 3Y4.25%
Revenue Next 5Y4.52%
EBIT growth 1Y-44.16%
EBIT growth 3Y-36.43%
EBIT growth 5Y-7.85%
EBIT Next Year142.59%
EBIT Next 3Y45.51%
EBIT Next 5Y26.96%
FCF growth 1Y-559.59%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y21.38%
OCF growth 3Y-5.63%
OCF growth 5Y5.61%

TERNIUM SA-SPONSORED ADR / TX Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for TERNIUM SA-SPONSORED ADR?

ChartMill assigns a fundamental rating of 4 / 10 to TX.


What is the valuation status of TERNIUM SA-SPONSORED ADR (TX) stock?

ChartMill assigns a valuation rating of 6 / 10 to TERNIUM SA-SPONSORED ADR (TX). This can be considered as Fairly Valued.


Can you provide the profitability details for TERNIUM SA-SPONSORED ADR?

TERNIUM SA-SPONSORED ADR (TX) has a profitability rating of 5 / 10.


What is the valuation of TERNIUM SA-SPONSORED ADR based on its PE and PB ratios?

The Price/Earnings (PE) ratio for TERNIUM SA-SPONSORED ADR (TX) is 19.93 and the Price/Book (PB) ratio is 0.71.


How financially healthy is TERNIUM SA-SPONSORED ADR?

The financial health rating of TERNIUM SA-SPONSORED ADR (TX) is 3 / 10.